Three mule deer wandered up to a brand-new bridge near Grass Lake, in the far north of California, and walked across it. The bridge was built just for them, and other animals, and a trail camera caught them taking advantage of it. Remarkably, the bridge was not even finished being built when they used it.…Continue reading The Kind of People Who Build Bridges for Animals
For years, the only way to fight against the weedkiller Roundup has been in a courtroom. Individuals who asserted that their lives had been forever altered by cancer from the weedkiller sued its maker, Bayer, which purchased the chemical’s original manufacturer, Monsanto, by the tens of thousands. At times, juries agreed with the plaintiffs and…Continue reading Kennedy Is in the Room. But Whose Science Is on the Table?
$53.5 billion. That is what twenty of the world’s largest grain, fertilizer, meat, and dairy companies paid their shareholders over 2021 and 2022. The United Nations estimates that it would cost about $51.5 billion to feed the 230 million most desperate, hungry people on earth. So a single slice of the food industry handed out…Continue reading $53.5 Billion: A Food System That Feeds Its Investors
Bill Gates is at it again. With funding from the U.S. Centers for Disease Control and Prevention (CDC) and the Bill and Melinda Gates Foundation, the first-ever clinical trial of a microarray injection-free vaccine has concluded, with children in Africa as young as nine months old “painlessly” being given measles and rubella vaccines through what…Continue reading Gates-Funded Needle-Free Drugs & Vaccines are on the Horizon
For the past 15 years, Bill Gates has been working on a project to open the most advanced nuclear facility in the world in Kemmerer, Wyoming. According to Gates, nuclear power is critical in the fight against climate change. With that in mind, he believes the world needs to “make a big bet on nuclear”…Continue reading Is Bill Gates Set to Control the U.S. & Global Nuclear Energy Markets?
Autism is on the rise, and the economic costs are projected to be staggering, according to a paper by Mark Blaxill, Political Economist Toby Rogers, Ph.D., M.P.P., and Cindy Nevison, Ph.D. Blaxill, Rogers, and Nevison studied the “monumental rise” in Autism and projected its societal and economic cost. Blaxill has co-authored three books on Autism.…Continue reading Del Bigtree Discusses the Escalating Cost of the Autism Tsunami
A study conducted on the effectiveness of the bivalent COVID-19 vaccine has surprised many at the Cleveland Clinic. The organization studied its employees to determine how the new bivalent vaccines stack up against some of the more prevalent COVID strains in circulation. The results weren’t what they expected. The study’s authors admit their surprise that…Continue reading Cleveland Clinic: More Boosters? More Likely to Get COVID-19
A triad of alarming events is happening alongside each other, interlaced with desperation for society to pay closer attention to people in need and the dangers of antidepressants. The failed pandemic response caused job loss and incomes to freefall for middle-class Americans. Those lower-income individuals were hit the hardest. The Great Barrington Declaration, whose authors and…Continue reading REVISITING ANTIDEPRESSANT DRUG DANGERS IN A POST-COVID WORLD
At the ReSViNET Conference in Lisbon, Portugal, in February 2023, GSK Vice President of Vaccine Development Ilse Dieussaert discloses why GSK abandoned its maternal RSVPreF3 vaccine trial last February. The study was a phase 3, double-blinded, saline placebo-controlled trial with participants across 24 different high and low-middle-income countries. The pregnant women were followed up to…Continue reading How GSK’s RSV Vaccine Safety Signal Opens Up Investigation for All Maternal Vaccines